Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AMY2A | P04746 | 8/20 | 0.56 |
| ▸ | MGAM | O43451 | 6/20 | 0.56 |
| ▸ | SI | P14410 | 5/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.56 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.56 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | TREH | O43280 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Validamycin A SCHEMBL29451180 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL15906030 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL10033386 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL14408718 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL14408710 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL8819801 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL16028080 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL19231832 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL14409005 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A | |
| Validamycin A SCHEMBL12347612 | 1.00 | AMY2A (0.56) | AMY2AMGAMSIGAAAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 727 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4114183-B1 | FUNGICIDAL COMPOSITIONS | SYNGENTA CROP PROTECTION AG (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| WO-2025223904-A1 | MIXTURES OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS WITH AT LEAST ONE FURTHER PESTICIDE I | BASF SE (DE) | 2025-10-30 | — | — | WO | claimed |
| WO-2025217346-A1 | COMPOSITIONS AND METHODS FOR CROP-PROTECTION AND USES THEREOF | TIDAL VISION PRODUCTS (US) | 2025-10-16 | — | — | WO | claimed |
| EP-3578543-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-08-20 | — | — | EP | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-120036142-A | High-altitude layering propagation method for dalbergia odorifera and application of high-altitude layering propagation method | 中国医学科学院药用植物研究所海南分所 | 2025-05-27 | — | — | CN | claimed |
| WO-2025092438-A1 | NICOTINIC ACID ESTER COMPOUND AND USE THEREOF | 青岛清原化合物有限公司 | 2025-05-08 | — | — | WO | claimed |
| WO-2025000181-A1 | GOSSYPOL-CONTAINING STEM BORER-KILLING COMPOSITION | 山东省农业科学院 | 2025-01-02 | — | — | WO | claimed |
| CN-104754943-A | Active compound combinations | BAYER CROPSCIENCE AG | 2015-07-01 | — | — | CN | claimed |
| CN-104754940-A | Active compound combinations | BAYER CROPSCIENCE AG | 2015-07-01 | — | — | CN | claimed |
| WO-2014037315-A2 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2014-03-13 | — | — | WO | claimed |
| WO-2014037314-A2 | ACTIVE COMPOUND COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2014-03-13 | — | — | WO | claimed |
| CN-103635089-A | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound | BAYER IP GMBH | 2014-03-12 | — | — | CN | claimed |
| US-20140038823-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGIDICAL COMPOUND | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2014-02-06 | — | — | US | claimed |
| EP-2515649-A2 | ACTIVE COMPOUND COMBINATIONS | Bayer Intellectual Property GmbH (DE) | 2012-10-31 | — | — | EP | claimed |
| EP-2398326-A1 | PESTICIDE COMPOSITION COMPRISING A TETRAZOLYLOXIME DERIVATIVE AND A FUNGICIDE OR AN INSECTICIDE ACTIVE SUBSTANCE | Bayer CropScience AG (DE) | 2011-12-28 | — | — | EP | claimed |
| WO-2010094728-A1 | PESTICIDE COMPOSITION COMPRISING A TETRAZOLYLOXIME DERIVATIVE AND A FUNGICIDE OR AN INSECTICIDE ACTIVE SUBSTANCE | BAYER CROPSCIENCE AG (DE) | 2010-08-26 | — | — | WO | claimed |
| EP-2014167-A1 | Active compound combinations | Bayer CropScience AG (DE) | 2009-01-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140038823-A1 | ACTIVE COMPOUND COMBINATIONS COMPRISING A (THIO)CARBOXAMIDE DERIVATIVE AND A FUNGIDICAL COMPOUND | AADAC, TUBA3C, NAT1 | AMY2A 3204/4885MGAM 71/4885SI 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.